Vaccine compositions and methods for restoring NKG2D pathway function against cancers
US10279021B2 · kind B2 · utility
1Cited by
43References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2015 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Jul 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6037
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for treating cancer in a subject by eliciting an immune response against a MIC polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.